OBJECTIVE: To analyse all available evidence to validate the effectiveness of a local intervention in the treatment of dyspareunia in breast cancer survivors (BCS). METHODS: We searched the Institute of Scientific Information Web of Knowledge, MEDLINE, PubMed, Scopus, and Cochrane databases for all articles published in peer-reviewed journals up to April 2019. The PICOS standards were: (population) BCS with dyspareunia; (intervention) any type of vulvovaginal treatment; (main outcome) frequency and severity of dyspareunia; (study design) clinical studies. RESULTS: The literature search strategy identified 252 articles, of which 233 were excluded at various stages of the search. Finally, we systematically reviewed 19 studies, 8 with local hormonal therapies, 7 with local non-hormonal therapies, 3 with laser therapy, and 1 with other interventions. Of the studies, 7 were randomized control trials and 11 were prospective observations. Most of the interventions were shown to be effective and safe in the improvement of dyspareunia. CONCLUSION: In addition to the traditional options already analysed in other current reviews, other interesting options are highlighted (such as laser or local dehydroepiandrosterone [DHEA]). Further work on dyspareunia should make use of high-quality trials with large numbers of samples to obtain evidence that could adequately demonstrate key methodological characteristics and harmful effects.
OBJECTIVE: To analyse all available evidence to validate the effectiveness of a local intervention in the treatment of dyspareunia in breast cancer survivors (BCS). METHODS: We searched the Institute of Scientific Information Web of Knowledge, MEDLINE, PubMed, Scopus, and Cochrane databases for all articles published in peer-reviewed journals up to April 2019. The PICOS standards were: (population) BCS with dyspareunia; (intervention) any type of vulvovaginal treatment; (main outcome) frequency and severity of dyspareunia; (study design) clinical studies. RESULTS: The literature search strategy identified 252 articles, of which 233 were excluded at various stages of the search. Finally, we systematically reviewed 19 studies, 8 with local hormonal therapies, 7 with local non-hormonal therapies, 3 with laser therapy, and 1 with other interventions. Of the studies, 7 were randomized control trials and 11 were prospective observations. Most of the interventions were shown to be effective and safe in the improvement of dyspareunia. CONCLUSION: In addition to the traditional options already analysed in other current reviews, other interesting options are highlighted (such as laser or local dehydroepiandrosterone [DHEA]). Further work on dyspareunia should make use of high-quality trials with large numbers of samples to obtain evidence that could adequately demonstrate key methodological characteristics and harmful effects.
Authors: Sabrina Witherby; Julia Johnson; Laurence Demers; Sharon Mount; Benjamin Littenberg; Charles D Maclean; Marie Wood; Hyman Muss Journal: Oncologist Date: 2011-03-08
Authors: Maria Ida Maiorino; Paolo Chiodini; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito Journal: Endocrine Date: 2015-12-07 Impact factor: 3.633
Authors: Peter Kenemans; Nigel J Bundred; Jean-Michel Foidart; Ernst Kubista; Bo von Schoultz; Piero Sismondi; Rena Vassilopoulou-Sellin; Cheng Har Yip; Jan Egberts; Mirjam Mol-Arts; Roel Mulder; Steve van Os; Matthias W Beckmann Journal: Lancet Oncol Date: 2009-01-23 Impact factor: 41.316
Authors: Susan M Seav; Sally A Dominick; Boris Stepanyuk; Jessica R Gorman; Diana T Chingos; Jennifer L Ehren; Michael L Krychman; H Irene Su Journal: Womens Midlife Health Date: 2015-11-02
Authors: Daniel María Lubián López; Carmen Aisha Butrón Hinojo; Manuel Sánchez-Prieto; Nicolás Mendoza; Rafael Sánchez-Borrego Journal: Breast Care (Basel) Date: 2020-10-23 Impact factor: 2.268